{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:27:13Z","timestamp":1787772433709,"version":"build-2784847793"},"reference-count":51,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>\n                    A\n                    <jats:sc>BSTRACT<\/jats:sc>\n                  <\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Polycystic ovarian syndrome (PCOS) is a gynaecological problem affecting women within reproductive age, accompanied by several metabolic anomalies, thus leading to alteration in kidney function and hyperuricaemia. Due to the high prevalence of cardiometabolic factors in PCOS, there is a need to anticipate an increased number of kidney impairments amongst these women.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>This review aims to investigate the potential link between PCOS, impaired kidney function, and elevated uric acid levels. By elucidating this association, we hope to provide clinicians with a tool to stratify the risk of kidney disease in women diagnosed with PCOS, based on readily available kidney function parameters.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>The recommendations used for the analysis were outlined in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 guidelines. Subsequently, eligible studies were identified using several databases (MEDLINE, ProQuest and EBSCOhost) between 1996 and 2022, with a total of 13 studies included. Serum uric acid, serum creatinine, as well as estimated glomerular filtration rate (eGFR) were evaluated as the outcome of interest. Quality assessment for cohort, case\u2013control and cross-sectional studies was conducted utilising the Newcastle\u2013Ottawa Scale, while Review Manager 5.4 was utilised for meta-analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Uric acid was significantly higher in women with PCOS (mean difference [MD] = 0.70, 95% confidence interval [CI] [0.45\u20130.95],\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.00001). Meanwhile, serum creatinine and eGFR were statistically similar in each group (MD = 0.08, 95% CI [\u22120.05\u20130.21],\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.22 and MD = 3.54, 95% CI [\u22124.53\u201311.61],\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.39, respectively).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interpretation:<\/jats:title>\n                    <jats:p>This review showed that PCOS was significantly associated with elevated uric acid. However, no significant difference was found between eGFR and creatinine levels compared to healthy controls. Routine uric acid assessment in PCOS patients is recommended as a simple tool for risk stratification.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Limitations:<\/jats:title>\n                    <jats:p>No body mass index (BMI) subgroup analysis was done due to limited BMI reporting in our included studies. Quantitative analysis of all kidney function parameters was also limited by sparse data on urea and albumin.<\/jats:p>\n                    <jats:p>\n                      <jats:bold>PROSPERO Registration Number:<\/jats:bold>\n                      CRD42023410092 (02 April 2023).\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jhrs.jhrs_31_24","type":"journal-article","created":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T03:02:10Z","timestamp":1716951730000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Association between Polycystic Ovarian Syndrome, Impaired Kidney Function and Hyperuricaemia: A Systematic Review and Meta-analysis"],"prefix":"10.4103","author":[{"given":"Nicolas Daniel","family":"Widjanarko","sequence":"first","affiliation":[{"name":"Pertamina Dumai Hospital, Dumai, Riau, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archie Fontana","family":"Iskandar","sequence":"additional","affiliation":[{"name":"Cimacan Regional General Hospital, Cianjur, West Java, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicia Grizelda","family":"Suryatenggara","sequence":"additional","affiliation":[{"name":"Pertamina Dumai Hospital, Dumai, Riau, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalia","family":"Sylfiasari","sequence":"additional","affiliation":[{"name":"Cililin Regional General Hospital, West Bandung Regency, West Java, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Leonardo","sequence":"additional","affiliation":[{"name":"Sejiran Setason Regional General Hospital, West Bangka Regency, Bangka Belitung Islands, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,5,28]]},"reference":[{"key":"R1-20240905","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.3390\/jcm12041454","article-title":"Polycystic ovary syndrome: Etiology, current management, and future therapeutics","volume":"12","author":"Singh","year":"2023","journal-title":"J Clin Med"},{"key":"R2-20240905","doi-asserted-by":"crossref","first-page":"16057","DOI":"10.1038\/nrdp.2016.57","article-title":"Polycystic ovary syndrome","volume":"2","author":"Azziz","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"R3-20240905","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nrendo.2018.24","article-title":"Polycystic ovary syndrome: Definition, aetiology, diagnosis and treatment","volume":"14","author":"Escobar-Morreale","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"R4-20240905","doi-asserted-by":"crossref","first-page":"869","DOI":"10.3390\/metabo11120869","article-title":"Metabolic syndrome and PCOS: Pathogenesis and the role of metabolites","volume":"11","author":"Chen","year":"2021","journal-title":"Metabolites"},{"key":"R5-20240905","doi-asserted-by":"crossref","first-page":"e14219","DOI":"10.14814\/phy2.14219","article-title":"Serum testosterone acts as a prognostic indicator in polycystic ovary syndrome-associated kidney injury","volume":"7","author":"Song","year":"2019","journal-title":"Physiol Rep"},{"key":"R6-20240905","doi-asserted-by":"crossref","first-page":"1120119","DOI":"10.3389\/fendo.2023.1120119","article-title":"Causal relationship between polycystic ovary syndrome and chronic kidney disease: A mendelian randomization study","volume":"14","author":"Du","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R7-20240905","first-page":"256","article-title":"The relationship between glomerular filtration rate, and metabolic and inflammatory parameters in obese and non-obese patients with polycystic ovary syndrome","volume":"32","author":"Can","year":"2020","journal-title":"Clin Investig Arterioscler"},{"key":"R8-20240905","first-page":"176","article-title":"Association of glomerular filtration rate with inflammation in polycystic ovary syndrome","volume":"9","author":"Gozukara","year":"2015","journal-title":"Int J Fertil Steril"},{"key":"R9-20240905","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1097\/HJH.0b013e328344db3a","article-title":"Renal denervation: A potential new treatment modality for polycystic ovary syndrome?","volume":"29","author":"Schlaich","year":"2011","journal-title":"J Hypertens"},{"key":"R10-20240905","doi-asserted-by":"crossref","first-page":"112","DOI":"10.4103\/aam.aam_15_22","article-title":"A study of hormonal and anthropometric parameters in polycystic ovarian syndrome","volume":"22","author":"Kambale","year":"2023","journal-title":"Ann Afr Med"},{"key":"R11-20240905","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12958-018-0419-x","article-title":"Association between the prevalence of hyperuricemia and reproductive hormones in polycystic ovary syndrome","volume":"16","author":"Mu","year":"2018","journal-title":"Reprod Biol Endocrinol"},{"key":"R12-20240905","doi-asserted-by":"crossref","first-page":"712855","DOI":"10.3389\/fendo.2021.712855","article-title":"Neck circumference is associated with hyperuricemia in women with polycystic ovary syndrome","volume":"12","author":"Yang","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R13-20240905","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1186\/s12902-022-01240-y","article-title":"Serum uric acid\/creatinine ratio and free androgen index are synergistically associated with increased risk of polycystic ovary syndrome in obese women","volume":"22","author":"El-Eshmawy","year":"2022","journal-title":"BMC Endocr Disord"},{"key":"R14-20240905","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"R15-20240905","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1177\/0962280216669183","article-title":"Optimally estimating the sample mean from the sample size, median, mid-range, and\/or mid-quartile range","volume":"27","author":"Luo","year":"2018","journal-title":"Stat Methods Med Res"},{"key":"R16-20240905","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"R18-20240905","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1093\/oxfordjournals.humrep.a019124","article-title":"Normal serum uric acid concentrations in women with polycystic ovary syndrome","volume":"11","author":"Anttila","year":"1996","journal-title":"Hum Reprod"},{"key":"R19-20240905","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1093\/humrep\/den095","article-title":"Serum uric acid concentration as non-classic cardiovascular risk factor in women with polycystic ovary syndrome: Effect of treatment with ethinyl-estradiol plus cyproterone acetate versus metformin","volume":"23","author":"Luque-Ram\u00edrez","year":"2008","journal-title":"Hum Reprod"},{"key":"R20-20240905","doi-asserted-by":"crossref","first-page":"782808","DOI":"10.3389\/fendo.2021.782808","article-title":"Correlation between serum uric acid and body fat distribution in patients with polycystic ovary syndrome","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R21-20240905","doi-asserted-by":"crossref","first-page":"100910","DOI":"10.1016\/j.cegh.2021.100910","article-title":"The role of high serum uric acid levels in androgenic and non-androgenic polycystic ovarian syndrome patients","volume":"12","author":"Pelluri","year":"2021","journal-title":"Clin Epidemiol Glob Health"},{"key":"R22-20240905","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0015-0282(01)01937-9","article-title":"Diastolic dysfunction and increased serum homocysteine concentrations may contribute to increased cardiovascular risk in patients with polycystic ovary syndrome","volume":"76","author":"Yarali","year":"2001","journal-title":"Fertil Steril"},{"key":"R23-20240905","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3109\/01443615.2011.569779","article-title":"Symmetric dimethylarginine (SDMA) is raised in women with polycystic ovary syndrome: A pilot study","volume":"31","author":"Lakhani","year":"2011","journal-title":"J Obstet Gynaecol"},{"key":"R24-20240905","first-page":"107","article-title":"Serum uric acid concentration in overweight and obese women with polycystic ovary syndrome\/nivelul acidului uric la femeile supraponderale \u015fi obeze cu sindromul ovarelor polichistice","volume":"23","author":"Leu\u015ftean","year":"2015","journal-title":"Rev Romana Med Lab"},{"key":"R25-20240905","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/cen.14284","article-title":"The risk of chronic kidney disease among women with polycystic ovary syndrome: A long-term population-based cohort study","volume":"93","author":"Behboudi-Gandevani","year":"2020","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R26-20240905","first-page":"719050","article-title":"Polycystic ovary syndrome, insulin resistance, and obesity: Navigating the pathophysiologic labyrinth","author":"Rojas","year":"2014","journal-title":"Int J Reprod Med 2014"},{"key":"R27-20240905","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.3390\/diagnostics13172814","article-title":"The hidden link between polycystic ovary syndrome and kidney stones: Finding from the Tehran lipid and glucose study (TLGS)","volume":"13","author":"Rostami","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"R28-20240905","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1093\/ckj\/sfz089","article-title":"Methods and reporting of kidney function: A systematic review of studies from sub-Saharan Africa","volume":"12","author":"Fabian","year":"2019","journal-title":"Clin Kidney J"},{"key":"R29-20240905","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.pcad.2018.07.005","article-title":"Obesity and kidney disease","volume":"61","author":"Lakkis","year":"2018","journal-title":"Prog Cardiovasc Dis"},{"key":"R30-20240905","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1093\/ckj\/sfab246","article-title":"Influence of race in the estimation of glomerular filtration rate in patients with a high cardiovascular and renal risk","volume":"15","author":"Ferreira","year":"2022","journal-title":"Clin Kidney J"},{"key":"R31-20240905","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1080\/00325481.2020.1761133","article-title":"Sex-specific differences in the prevalence of and risk factors for hyperuricemia among a low-income population in China: A cross-sectional study","volume":"132","author":"Qi","year":"2020","journal-title":"Postgrad Med"},{"key":"R32-20240905","first-page":"991","article-title":"Level of serum creatinine and creatinine clearance rate in obese female","volume":"30","author":"Meherubin","year":"2021","journal-title":"Mymensingh Med J"},{"key":"R33-20240905","doi-asserted-by":"crossref","first-page":"4911","DOI":"10.2147\/DMSO.S344894","article-title":"Risk predictors of high uric acid levels among patients with type-2 diabetes","volume":"14","author":"Eljaaly","year":"2021","journal-title":"Diabetes Metab Syndr Obes"},{"key":"R34-20240905","first-page":"273","article-title":"Evaluation of serum uric acid and serum creatinine in male hypertensive patients","volume":"29","author":"Firoz","year":"2020","journal-title":"Mymensingh Med J"},{"key":"R35-20240905","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s11906-012-0250-2","article-title":"Lipid nephrotoxicity: New concept for an old disease","volume":"14","author":"Gyebi","year":"2012","journal-title":"Curr Hypertens Rep"},{"key":"R36-20240905","doi-asserted-by":"crossref","first-page":"e293","DOI":"10.1097\/01.hjh.0000747832.74962.b1","article-title":"Muscle mass and estimated renal function in athletes","volume":"39","author":"Yasuda","year":"2021","journal-title":"J Hypertens"},{"key":"R37-20240905","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4239\/wjd.v3.i1.1","article-title":"Renal hyperfiltration related to diabetes mellitus and obesity in human disease","volume":"3","author":"Sasson","year":"2012","journal-title":"World J Diabetes"},{"key":"R38-20240905","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.5455\/OVJ.2023.v13.i8.6","article-title":"Evaluation of renal disturbance in animal models of polycystic ovary syndrome","volume":"13","author":"Oktanella","year":"2023","journal-title":"Open Vet J"},{"key":"R39-20240905","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1681\/ASN.2016060666","article-title":"Glomerular hyperfiltration in diabetes: Mechanisms, clinical significance, and treatment","volume":"28","author":"Tonneijck","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"R40-20240905","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.genm.2010.11.013","article-title":"Cardiovascular-renal and metabolic characterization of a rat model of polycystic ovary syndrome","volume":"8","author":"Yanes","year":"2011","journal-title":"Gend Med"},{"key":"R41-20240905","doi-asserted-by":"crossref","first-page":"872918","DOI":"10.3389\/fendo.2022.872918","article-title":"Update on pathogenesis of glomerular hyperfiltration in early diabetic kidney disease","volume":"13","author":"Yang","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R42-20240905","doi-asserted-by":"crossref","first-page":"e75547","DOI":"10.1371\/journal.pone.0075547","article-title":"Proximal tubular hypertrophy and enlarged glomerular and proximal tubular urinary space in obese subjects with proteinuria","volume":"8","author":"Tobar","year":"2013","journal-title":"PLoS One"},{"key":"R43-20240905","doi-asserted-by":"crossref","first-page":"F819","DOI":"10.1152\/ajprenal.00497.2016","article-title":"Primary proximal tubule hyperreabsorption and impaired tubular transport counterregulation determine glomerular hyperfiltration in diabetes: A modeling analysis","volume":"312","author":"Hallow","year":"2017","journal-title":"Am J Physiol Renal Physiol"},{"key":"R44-20240905","doi-asserted-by":"crossref","first-page":"925619","DOI":"10.3389\/fnut.2022.925619","article-title":"Obesity-related chronic kidney disease: Principal mechanisms and new approaches in nutritional management","volume":"9","author":"Stasi","year":"2022","journal-title":"Front Nutr"},{"key":"R45-20240905","doi-asserted-by":"crossref","first-page":"R99","DOI":"10.1530\/JOE-16-0405","article-title":"Hormonal alterations in PCOS and its influence on bone metabolism","volume":"232","author":"Krishnan","year":"2017","journal-title":"J Endocrinol"},{"key":"R46-20240905","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.4236\/ojog.2018.813147","article-title":"Hormonal imbalance in polycystic ovarian syndrome (PCOS) in teaching hospitals in Ekiti State, Nigeria","volume":"8","author":"Oyebanji","year":"2018","journal-title":"Open J Obstet Gynecol"},{"key":"R47-20240905","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1055\/s-2007-1004914","article-title":"Influence of testosterone on purine nucleotide turnover in rat kidney","volume":"22","author":"Pizzichini","year":"1990","journal-title":"Horm Metab Res"},{"key":"R48-20240905","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1055\/s-2004-825923","article-title":"Effect of testosterone on purine nucleotide metabolism in rat liver","volume":"36","author":"Marinello","year":"2004","journal-title":"Horm Metab Res"},{"key":"R49-20240905","first-page":"e3158","article-title":"Effects of body mass index, glycemic control, and hypoglycemic drugs on serum uric acid levels in type 2 diabetic patients","volume":"10","author":"Hussain","year":"2018","journal-title":"Cureus"},{"key":"R50-20240905","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0026-0495(98)90346-8","article-title":"Effect of visceral fat accumulation on uric acid metabolism in male obese subjects: Visceral fat obesity is linked more closely to overproduction of uric acid than subcutaneous fat obesity","volume":"47","author":"Matsuura","year":"1998","journal-title":"Metabolism"},{"key":"R51-20240905","doi-asserted-by":"crossref","first-page":"e0206850","DOI":"10.1371\/journal.pone.0206850","article-title":"Prevalence of hyperuricemia and the relationship between serum uric acid and obesity: A study on Bangladeshi adults","volume":"13","author":"Ali","year":"2018","journal-title":"PLoS One"},{"key":"R52-20240905","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s12199-015-0473-3","article-title":"The relationship between body mass index and uric acid: A study on Japanese adult twins","volume":"20","author":"Tanaka","year":"2015","journal-title":"Environ Health Prev Med"}],"container-title":["Journal of Human Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jhrs.jhrs_31_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T18:46:28Z","timestamp":1787769988000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jhrs.jhrs_31_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,28]]},"references-count":51,"URL":"https:\/\/doi.org\/10.4103\/jhrs.jhrs_31_24","relation":{},"ISSN":["0974-1208","1998-4766"],"issn-type":[{"value":"0974-1208","type":"print"},{"value":"1998-4766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,28]]},"assertion":[{"value":"2024-03-02","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-08","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}